Avoiding gender and minority barriers to NIH funding
Avoiding gender and minority barriers to NIH funding
复制标题
DOI：
10.1111/j.1547-5069.2000.00083.x
复制
发表时间：
2000-01-01
影响因子：
3.4
通讯作者：
McFarland, G
中科院分区：
文献类型：
--
作者：
Harden, JT;McFarland, G
目的：向研究人员通报美国国立卫生研究院(NIH)将妇女和少数族裔纳入临床研究对象的指导方针，并提供有关避免联邦资助障碍的提示。方法：通过审查NIH的政策、申请者提交的信息和NIH审查员提供的评论，获得有关性别和少数族裔资助障碍的信息。组织框架：描述美国联邦立法增加获得信息的机会的目标的简要历史，以帮助提高所有美国人的健康和疾病治疗，并发现和考虑种族和性别差异。这些例子来自NIH初步审查小组的摘要声明评论。结论：如果初步审查小组认为纳入妇女和少数族裔的计划在科学上不可接受，则提交给NIH的申请将被禁止初始资助，即使优先分数很高。这种情况是可以纠正和避免的。
Purpose: To inform investigators of the National Institutes of Health (NIH) guidelines for the inclusion of women and minorities as subjects in clinical research and provide tips on avoiding barriers to federal funding.Methods: Information about gender and minority barriers to funding was obtained by reviewing NIH policies, information submitted by applicants, and comments provided by NIH reviewers.Organizing Framework: A brief history of the goals of U.S. federal legislation to increase opportunities for obtaining information to help enhance health and disease treatment for all Americans and to detect and account for ethnic and gender differences is described. Examples were derived from NIH Summary Statement comments of initial review groups.Conclusions: Applications submitted to NIH are being barred from initial funding, even with excellent priority scores, if the plan for inclusion of women and minorities is judged to be scientifically unacceptable by the initial review group. This situation is correctable and avoidable.